Advertisement

Journal of NeuroVirology

, Volume 14, Issue 3, pp 229–238 | Cite as

Microglia are the major cellular source of inducible nitric oxide synthase during experimental herpes encephalitis

  • Cristina P. Marques
  • Maxim C. -J. Cheeran
  • Joseph M. Palmquist
  • Shuxian Hu
  • James R. LokensgardEmail author
Article

Abstract

Although production of reactive nitrogen and reactive oxygen species (RNS and ROS) is a component of innate defense against viral infection, their overproduction in the brain may also lead to deleterious consequences. To investigate potential immunopathologic roles of oxidative stress during herpes encephalitis, the authors examined the expression kinetics of inducible nitric oxide synthase (iNOS) as well as heme oxygenase-1 (HO-1), a marker of oxidative stress, and evaluated infection-induced oxidative brain damage. Results from these studies showed that both iNOS and HO-1 gene expression were highly elevated in the brain within 7 days post infection (d.p.i.) and remained elevated through 21 d.p.i. Real-time bioluminescence imaging of HO-1 promoter-luciferase transgenic mice confirmed HO-1 promoter activity in the brains of HSV-1-infected animals within 3 d.p.i., which peaked between 5 and 7 d.p.i. Immunohistochemical staining for both 3-nitrotyrosine and 8-hydroxydeoxyguanosine (8-OH-dG), as well as quantitative assessment of 8-isoprostane levels, demonstrated the presence of viral infection-induced oxidative brain damage. In addition, when brain leukocytes obtained from animals with experimental herpes encephalitis were sorted using fluorescence-activated cell sorting (FACS) and the individual cell populations analyzed, CD45(int)/CD11b(+) resident microglia were found to be the major cellular source of iNOS expression.

Keywords

HO-1 HSV iNOS microglia oxidative stress 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adler H, Beland JL, Del-Pan NC, Kobzik L, Brewer JP, Martin TR, Rimm IJ (1997). Suppression of herpes simplex virus type 1 (HSV-1)-induced pneumonia in mice by inhibition of inducible nitric oxide synthase (iNOS, NOS2). J Exp Med 185: 1533–1540.PubMedCrossRefGoogle Scholar
  2. Baranano DE, Snyder SH (2001). Neural roles for heme oxygenase: contrasts to nitric oxide synthase. Proc Natl Acad Sci U S A 98: 10996–1002.PubMedCrossRefGoogle Scholar
  3. Blais V, Rivest S (2004). Effects of TNF-alpha and IFN-gamma on nitric oxide-induced neurotoxicity in the mouse brain. J Immunol 172: 7043–7052.PubMedGoogle Scholar
  4. Bredt DS, Snyder SH (1992). Nitric oxide, a novel neuronal messenger. Neuron 8: 3–11.PubMedCrossRefGoogle Scholar
  5. Chen M, Regan RF (2007). Time course of increased heme oxygenase activity and expression after experimental intracerebral hemorrhage: correlation with oxidative injury. J Neurochem 103: 2015–2021.PubMedCrossRefGoogle Scholar
  6. Chen-Roetling J, Benvenisti-Zarom L, Regan RF (2005). Cultured astrocytes from heme oxygenase-1 knockout mice are more vulnerable to heme-mediated oxidative injury. J Neurosci Res 82: 802–810.PubMedCrossRefGoogle Scholar
  7. Chora AA, Fontoura P, Cunha A, Pais TF, Cardoso S, Ho PP, Lee LY, Sobel RA, Steinman L, Soares MP (2007). Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation. J Clin Invest 117: 438–447.PubMedCrossRefGoogle Scholar
  8. Croen KD (1993). Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J Clin Invest 91: 2446–2452.PubMedCrossRefGoogle Scholar
  9. Ford AL, Goodsall AL, Hickey WF, Sedgwick JD (1995). Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J Immunol 154: 4309–4321.PubMedGoogle Scholar
  10. Fujii S, Akaike T, Maeda H (1999). Role of nitric oxide in pathogenesis of herpes simplex virus encephalitis in rats. Virology 256: 203–212.PubMedCrossRefGoogle Scholar
  11. Gamba G, Cavalieri H, Courreges MC, Massouh EJ, Benencia F (2004). Early inhibition of nitric oxide production increases HSV-1 intranasal infection. J Med Virol 73: 313–322.PubMedCrossRefGoogle Scholar
  12. Garthwaite J (1991). Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 14: 60–67.PubMedCrossRefGoogle Scholar
  13. Irie H, Shiga J (2005). Pathogenesis of herpes simplex hepatitis in macrophage-depleted mice: possible involvement of tumor necrosis factor-alpha and inducible nitric oxide synthase in massive apoptosis. Anat Sci Int 80: 199–211.PubMedCrossRefGoogle Scholar
  14. Kavouras JH, Prandovszky E, Valyi-Nagy K, Kovacs SK, Tiwari V, Kovacs M, Shukla D, Valyi-Nagy T (2007). Herpes simplex virus type 1 infection induces oxidative stress and the release of bioactive lipid peroxidation by-products in mouse P19N neural cell cultures. J NeuroVirol 13: 416–425.PubMedCrossRefGoogle Scholar
  15. Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–408.PubMedCrossRefGoogle Scholar
  16. Lokensgard JR, Hu S, Sheng W, vanOijen M, Cox D, Cheeran MC, Peterson PK (2001). Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus. J NeuroVirol 7: 208–219.PubMedCrossRefGoogle Scholar
  17. Luker GD, Prior JL, Song J, Pica CM, Leib DA (2003). Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors. J Virol 77: 11082–11093.PubMedCrossRefGoogle Scholar
  18. MacLean A, Wei XQ, Huang FP, Al-Alem UA, Chan WL, Liew FY (1998). Mice lacking inducible nitric-oxide synthase are more susceptible to herpes simplex virus infection despite enhanced Th1 cell responses. J Gen Virol 79(Pt 4): 825–830.PubMedGoogle Scholar
  19. Malstrom SE, Jekic-McMullen D, Sambucetti L, Ang A, Reeves R, Purchio AF, Contag PR, West DB (2004). In vivo bioluminescent monitoring of chemical toxicity using heme oxygenase-luciferase transgenic mice. Toxicol Appl Pharmacol 200: 219–228.PubMedCrossRefGoogle Scholar
  20. Marques CP, Hu S, Sheng W, Cheeran MC, Cox D, Lokensgard JR (2004). Interleukin-10 attenuates production of HSV-induced inflammatory mediators by human microglia. Glia 47: 358–366.PubMedCrossRefGoogle Scholar
  21. Marques CP, Hu S, Sheng W, Lokensgard JR (2006). Microglial cells initiate vigorous yet non-protective immune responses during HSV-1 brain infection. Virus Res 121: 1–10.PubMedCrossRefGoogle Scholar
  22. Marten NW, Stohlman SA, Zhou J, Bergmann CC (2003). Kinetics of virus-specific CD8+ T-cell expansion and trafficking following central nervous system infection. J Virol 77: 2775–2778.PubMedCrossRefGoogle Scholar
  23. Martin LD, Krunkosky TM, Dye JA, Fischer BM, Jiang NF, Rochelle LG, Akley NJ, Dreher KL, Adler KB (1997). The role of reactive oxygen and nitrogen species in the response of airway epithelium to particulates. Environ Health Perspect 105(Suppl 5): 1301–1307.PubMedCrossRefGoogle Scholar
  24. Milatovic D, Zhang Y, Olson SJ, Montine KS, Roberts LJ 2nd, Morrow JD, Montine TJ, Dermody TS, Valyi-Nagy T (2002). Herpes simplex virus type 1 encephalitis is associated with elevated levels of F2-isoprostanes and F4-neuroprostanes. J NeuroVirol 8: 295–305.PubMedCrossRefGoogle Scholar
  25. Moncada S, Palmer RM, Higgs EA (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109–142.PubMedGoogle Scholar
  26. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Oates JA, Roberts LJ 2nd (1995). Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N Engl J Med 332: 1198–1203.PubMedCrossRefGoogle Scholar
  27. Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ, 2nd (1990). A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci U S A 87: 9383–9387.PubMedCrossRefGoogle Scholar
  28. Musallam B, Matoth I, Wolf DG, Engelhard D, Averbuch D (2007). Steroids for deteriorating herpes simplex virus encephalitis. Pediatr Neurol 37: 229–232.PubMedCrossRefGoogle Scholar
  29. Nathan CF, Hibbs JB Jr (1991). Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 3: 65–70.PubMedCrossRefGoogle Scholar
  30. Ono S, Komuro T, Macdonald RL (2002). Heme oxygenase-1 gene therapy for prevention of vasospasm in rats. J Neurosurg 96: 1094–1102.PubMedCrossRefGoogle Scholar
  31. Regan RF, Guo Y, Kumar N (2000). Heme oxygenase-1 induction protects murine cortical astrocytes from hemoglobin toxicity. Neurosci Lett 282: 1–4.PubMedCrossRefGoogle Scholar
  32. Reilly MP, Delanty N, Roy L, Rokach J, Callaghan PO, Crean P, Lawson JA, FitzGerald GA (1997). Increased formation of the isoprostanes IPF2alpha-I and 8-epi-prostaglandin F2alpha in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Circulation 96: 3314–3320.PubMedGoogle Scholar
  33. Reynolds A, Laurie C, Mosley RL, Gendelman HE (2007a). Oxidative stress and the pathogenesis of neurodegenerative disorders. Int Rev Neurobiol 82: 297–325.PubMedCrossRefGoogle Scholar
  34. Reynolds AD, Banerjee R, Liu J, Gendelman HE, Mosley RL (2007b). Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson’s disease. J Leukoc Biol 82: 1083–1094.PubMedCrossRefGoogle Scholar
  35. Sato K, Balla J, Otterbein L, Smith RN, Brouard S, Lin Y, Csizmadia E, Sevigny J, Robson SC, Vercellotti G, Choi AM, Bach FH, Soares MP (2001). Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants. J Immunol 166: 4185–4194.PubMedGoogle Scholar
  36. Sergerie Y, Boivin G, Gosselin D, Rivest S (2007). Delayed but not early glucocorticoid treatment protects the host during experimental herpes simplex virus encephalitis in mice. J Infect Dis 195: 817–825.PubMedCrossRefGoogle Scholar
  37. Silva G, Cunha A, Gregoire IP, Seldon MP, Soares MP (2006). The antiapoptotic effect of heme oxygenase-1 in endothelial cells involves the degradation of p38 alpha MAPK isoform. J Immunol 177: 1894–1903.PubMedGoogle Scholar
  38. Turcanu V, Dhouib M, Poindron P (1998a). Heme oxygenase inhibits nitric oxide synthase by degrading heme: a negative feedback regulation mechanism for nitric oxide production. Transplant Proc 30: 4184–4185.PubMedCrossRefGoogle Scholar
  39. Turcanu V, Dhouib M, Poindron P (1998b). Nitric oxide synthase inhibition by haem oxygenase decreases macrophage nitric-oxide-dependent cytotoxicity: a negative feedback mechanism for the regulation of nitric oxide production. Res Immunol 149: 741–744.PubMedCrossRefGoogle Scholar
  40. Valyi-Nagy T, Olson SJ, Valyi-Nagy K, Montine TJ, Dermody TS (2000). Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons. Virology 278: 309–321.PubMedCrossRefGoogle Scholar
  41. Zhang W, Contag PR, Hardy J, Zhao H, Vreman HJ, Hajdena-Dawson M, Wong RJ, Stevenson DK, Contag CH (2002). Selection of potential therapeutics based on in vivo spatiotemporal transcription patterns of heme oxygenase-1. J Mol Med 80: 655–664.PubMedCrossRefGoogle Scholar
  42. Zhang W, Contag PR, Madan A, Stevenson DK, Contag CH (1999). Bioluminescence for biological sensing in living mammals. Adv Exp Med Biol 471: 775–784.PubMedGoogle Scholar
  43. Zhang W, Feng JQ, Harris SE, Contag PR, Stevenson DK, Contag CH (2001). Rapid in vivo functional analysis of transgenes in mice using whole body imaging of luciferase expression. Transgenic Res 10: 423–434.PubMedCrossRefGoogle Scholar

Copyright information

© Journal of NeuroVirology, Inc. 2008

Authors and Affiliations

  • Cristina P. Marques
    • 1
  • Maxim C. -J. Cheeran
    • 1
  • Joseph M. Palmquist
    • 1
  • Shuxian Hu
    • 1
  • James R. Lokensgard
    • 1
    Email author
  1. 1.Neuroimmunology Laboratory, Center for Infectious Diseases and Microbiology Translational ResearchUniversity of Minnesota Medical SchoolMinneapolisUSA

Personalised recommendations